If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

New research shows patients with Parkinson's disease were more willing to help others after taking their dopamine-boosting ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

Discover the impact of dopamine on the brain's reward circuit, from pleasure to addiction, and how to find balance.

A research team from the University of Cologne conducted one of the most comprehensive studies on dopamine and ...

In one of the largest studies of its kind, researchers found that increasing dopamine levels with L-DOPA made people slightly ...

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.

The 2025 AASM guidelines recommend iron supplementation as the first-line treatment for RLS when ferritin levels are below 75 ng/mL. Dopamine agonists like ropinirole can reduce RLS symptoms but carry ...

A drug most often prescribed for diabetes and obesity might soon be prescribed to curb one of the world’s hardest to quit ...

LOS ANGELES — Maybe you'd like to spend time on hobbies or hang out with friends, but nothing feels as exciting and engaging as it used to –– so you just squander another hour on social media. Your ...